Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (451-460 of 633) with videos related to

Pageof 64
Sort By:
Frontiers in Oncology|June 9, 2022
ERH Gene and Its Role in Cancer CellsKun Pang, Mei-Li Li, Lin Hao, et al.
Frontiers in Oncology|May 21, 2019
Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer CellsQingbin Cui, Chao-Yun Cai, Hai-Ling Gao, et al.
Journal of Cancer|November 22, 2017
The Prognostic Value of Peripheral Benzodiazepine Receptor in Patients with Esophageal Squamous Cell CarcinomaYou-Fang Chen, Jing-Dun Xie, Yu-Chuan Jiang, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 20, 2008
[Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer]Xiao-dong Su, Xin Wang, Tie-hua Rong, et al.
Frontiers in Cell and Developmental Biology|March 22, 2021
OGP46 Induces Differentiation of Acute Myeloid Leukemia Cells via Different Optimal Signaling PathwaysMin Zhao, Jiangyun Wang, Mei Qu, et al.
Molecular Cancer|February 11, 2022
Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinomaHuibin Song, Dongcheng Liu, Lingwei Wang, et al.
Frontiers in Oncology|July 18, 2020
Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer CellsYi-Dong Li, Yong Mao, Xing-Duo Dong, et al.
Frontiers in Oncology|June 2, 2020
Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells <i>in vitro</i>Yuqi Yang, Ning Ji, Qiu-Xu Teng, et al.
Journal of Translational Internal Medicine|July 31, 2024
RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cellsXing-Duo Dong, Qisi Lu, Yi-Dong Li, et al.
International Journal of Molecular Sciences|February 26, 2020
Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer CellsJingqiu Wang, Dong-Hua Yang, Yuqi Yang, et al.
Pageof 64

Showing results (451-460 of 633) with videos related to

Sort By:
Pageof 64
Frontiers in Oncology|June 9, 2022
ERH Gene and Its Role in Cancer CellsKun Pang, Mei-Li Li, Lin Hao, et al.
Frontiers in Oncology|May 21, 2019
Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer CellsQingbin Cui, Chao-Yun Cai, Hai-Ling Gao, et al.
Journal of Cancer|November 22, 2017
The Prognostic Value of Peripheral Benzodiazepine Receptor in Patients with Esophageal Squamous Cell CarcinomaYou-Fang Chen, Jing-Dun Xie, Yu-Chuan Jiang, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 20, 2008
[Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer]Xiao-dong Su, Xin Wang, Tie-hua Rong, et al.
Frontiers in Cell and Developmental Biology|March 22, 2021
OGP46 Induces Differentiation of Acute Myeloid Leukemia Cells via Different Optimal Signaling PathwaysMin Zhao, Jiangyun Wang, Mei Qu, et al.
Molecular Cancer|February 11, 2022
Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinomaHuibin Song, Dongcheng Liu, Lingwei Wang, et al.
Frontiers in Oncology|July 18, 2020
Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer CellsYi-Dong Li, Yong Mao, Xing-Duo Dong, et al.
Frontiers in Oncology|June 2, 2020
Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells <i>in vitro</i>Yuqi Yang, Ning Ji, Qiu-Xu Teng, et al.
Journal of Translational Internal Medicine|July 31, 2024
RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cellsXing-Duo Dong, Qisi Lu, Yi-Dong Li, et al.
International Journal of Molecular Sciences|February 26, 2020
Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer CellsJingqiu Wang, Dong-Hua Yang, Yuqi Yang, et al.
Pageof 64